Atopic eczema
Clinical trials for Atopic eczema explained in plain language.
Never miss a new study
Get alerted when new Atopic eczema trials appear
Sign up with your email to follow new studies for Atopic eczema, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Eczema drug dupilumab shows promise in skin of color patients
Disease control CompletedThis study tested the drug dupilumab (Dupixent) in 124 adolescents and adults with darker skin tones who have moderate-to-severe eczema. Participants received injections every two weeks for 24 weeks. The goal was to see if the drug safely improves skin symptoms and quality of lif…
Matched conditions: ATOPIC ECZEMA
Phase 4 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug ATTO1310 tested for eczema and itch relief
Symptom relief CompletedThis early-stage study tests a new drug called ATTO1310 to see if it is safe and how the body processes it. It includes healthy adults, people with atopic dermatitis (eczema), and those with long-term itching. Participants receive either the drug or a placebo and are monitored fo…
Matched conditions: ATOPIC ECZEMA
Phase 1 • Sponsor: Attovia Therapeutics Inc • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
New eczema drug ATTO-3712 enters early human safety trials
Symptom relief CompletedThis early-stage study tests a new drug called ATTO-3712 in healthy adults and people with atopic dermatitis (eczema). The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo and are monitored with clinic visi…
Matched conditions: ATOPIC ECZEMA
Phase 1 • Sponsor: Attovia Therapeutics Inc • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC